About this Research Topic
The 36th World Congress of Audiology (WCA) in 2024 marks a significant milestone in the fields of audiology and otology. After nearly half a century, this event has returned to France, bringing together audiologists, researchers, and experts from across the globe.
The WCA 2024 is putting out a call for participating to a special congress session to feature emerging research discoveries that will drive the next wave of therapeutic and device innovation.
To highlight the scientific outcomes of the event, Frontiers in Audiology and Otology is hosting this Research Topic article collection to cover emerging innovations that will shape the future of the field.
Areas of focus include, but are not limited to:
- The process of innovation
- In-Office tympanic perforation treatments
- Tinnitus therapeutics
- Implantable hearing devices
- Genomics and biomarkers
- Inner ear genetics
- Inner ear regeneration
- Inner ear immunology
- Nanomedicines in otology
- Vestibular monitoring devices
- Neural coding and cortical behaviour
- Hyperacusis therapies
Presenters selected for the WCA conference are welcome to contribute to this Research Topic of Frontiers in Audiology and Otology with manuscripts in the form of Reviews or Mini-Reviews, showcasing the highlights from their presentations.
Articles accepted after peer review will be published and appear online as soon as accepted for publication.
Dr. Peter Santa Maria holds founding shares in Audience and is a founder of Auration Biotech, Earflo, and Flotherm Inc. Dr. Anais Rameau shares ownership in Perceptron Health Inc. and acts as a medical advisor to Sound Health Inc. Dr. Peter Kullar is the Medical Director at Stemnovate Limited. Dr. Bernard Fraysse has received research funding from Amplifon and Archean Technologies. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
The WCA 2024 is putting out a call for participating to a special congress session to feature emerging research discoveries that will drive the next wave of therapeutic and device innovation.
To highlight the scientific outcomes of the event, Frontiers in Audiology and Otology is hosting this Research Topic article collection to cover emerging innovations that will shape the future of the field.
Areas of focus include, but are not limited to:
- The process of innovation
- In-Office tympanic perforation treatments
- Tinnitus therapeutics
- Implantable hearing devices
- Genomics and biomarkers
- Inner ear genetics
- Inner ear regeneration
- Inner ear immunology
- Nanomedicines in otology
- Vestibular monitoring devices
- Neural coding and cortical behaviour
- Hyperacusis therapies
Presenters selected for the WCA conference are welcome to contribute to this Research Topic of Frontiers in Audiology and Otology with manuscripts in the form of Reviews or Mini-Reviews, showcasing the highlights from their presentations.
Articles accepted after peer review will be published and appear online as soon as accepted for publication.
Dr. Peter Santa Maria holds founding shares in Audience and is a founder of Auration Biotech, Earflo, and Flotherm Inc. Dr. Anais Rameau shares ownership in Perceptron Health Inc. and acts as a medical advisor to Sound Health Inc. Dr. Peter Kullar is the Medical Director at Stemnovate Limited. Dr. Bernard Fraysse has received research funding from Amplifon and Archean Technologies. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Keywords: audiology, otology, innovations
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
